Liver resection with two-step vascular exclusion, in situ hypothermic portal perfusion for the treatment of end-stage hepatic alveolar echinococcosis.
In situ hypothermic portal perfusion
Total vascular exclusion
Vessels reconstruction
Journal
Langenbeck's archives of surgery
ISSN: 1435-2451
Titre abrégé: Langenbecks Arch Surg
Pays: Germany
ID NLM: 9808285
Informations de publication
Date de publication:
30 May 2024
30 May 2024
Historique:
received:
14
04
2024
accepted:
13
05
2024
medline:
31
5
2024
pubmed:
31
5
2024
entrez:
31
5
2024
Statut:
epublish
Résumé
To evaluate the safety and efficacy of two-step vascular exclusion and in situ hypothermic portal perfusion in patients with end-stage hepatic hydatidosis. This study involved patients with advanced hepatic hydatid disease undergoing surgical treatment between 2022 and 2023, which included resection and reconstruction of the hepatic veins, inferior vena cava (IVC), and portal vein (PV). We described the technical details of liver resection and vascular reconstruction, as well as the use of two-step vascular exclusion and in situ hypothermic portal perfusion techniques during the vascular reconstruction process. We included 7 patients with advanced hepatic hydatid disease who underwent surgical resection using two-step vascular exclusion and in situ hypothermic portal perfusion. The mean duration of surgery was 12.5 h (range, 7.5-15.0 h). The average hepatic ischemia time was 45 min (range, 25-77 min), while the occlusion time of the IVC was 87 min (range, 72-105 min). The total blood loss was 1000 milliliters (range, 500-1250 milliliters). Postoperatively, patients exhibited good recovery of liver and renal function. The mean ICU stay was 2 days (range, 1-3 days), and the mean postoperative hospital stay was 13 days (range, 9-16 days), with no Grade III or above complications observed during a mean follow-up period of 15 months (range, 9-24 months), CONCLUSION: two-step vascular exclusion and in situ hypothermic portal perfusion for surgical resection of end-stage hepatic hydatid disease is safe and effective. This significantly reduces the anhepatic time.
Identifiants
pubmed: 38819706
doi: 10.1007/s00423-024-03351-7
pii: 10.1007/s00423-024-03351-7
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
168Subventions
Organisme : Youth Talent Fund of Sichuan Provincial People's Hospital
ID : NO. 2022QN53
Organisme : Science and Technology Department of Sichuan Province
ID : NO. 2021YFS0375
Organisme : Science and Technology Department of Sichuan Province
ID : NO. 2022YFS0596
Organisme : Natural Science Foundation of Henan Province
ID : 82373189
Informations de copyright
© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Références
McManus DP, Zhang W, Li J et al (2003) Echinococcosis Lancet 362:1295–1304
doi: 10.1016/S0140-6736(03)14573-4
pubmed: 14575976
Kern P (2010) Clinical features and treatment of alveolar echinococcosis. Curr Opin Infect Dis 23:505–512
doi: 10.1097/QCO.0b013e32833d7516
pubmed: 20683265
McManus DP, Gray DJ, Zhang W et al (2012) Diagnosis, treatment, and management of echinococcosis. BMJ 344:e3866
doi: 10.1136/bmj.e3866
pubmed: 22689886
Yang C, Yang HJ, Deng SP, Zhang Y (2020). Current status of ex-vivo liver resection and autologous liver transplantation for end-stage hepatic alveolar echinococcosis. Ann Palliat Med. 9(4):2271–2278. https://doi.org/10.21037/apm-20-184
Fortner JG, Shiu MH, Kinne DW et al (1974) Major hepatic resection using vascular isolation and hypothermic perfusion. Ann Surg 180:644–652
doi: 10.1097/00000658-197410000-00030
pubmed: 4414545
pmcid: 1344161
Yang X, Qiu Y, Huang B et al (2018) Novel techniques and preliminary results of ex vivo liver resection and autotransplantation for end-stage hepatic alveolar echinococcosis: a study of 31 cases. Am J Transpl 18(7):1668–1679. https://doi.org/10.1111/ajt.14621
doi: 10.1111/ajt.14621
Azoulay D, Andreani P, Maggi U et al (2006) Combined liver resection and reconstruction of the supra-renal vena cava: the Paul Brousse experience. Ann Surg 244(1):80–88. https://doi.org/10.1097/01.sla.0000218092.83675
doi: 10.1097/01.sla.0000218092.83675
pubmed: 16794392
pmcid: 1570596
Tongyoo A, Pomfret EA, Pomposelli JJ (2012) Accurate estimation of living donor right hemi-liver volume from portal vein diameter measurement and standard liver volume calculation. Am J Transpl 12:1229–1239
doi: 10.1111/j.1600-6143.2011.03909.x
Urata K, Kawasaki S, Matsunami H et al (1995) Calculation of child and adult standard liver volume for liver transplantation. Hepatology 21:1317–1321
doi: 10.1002/hep.1840210515
pubmed: 7737637
Azoulay D, Castaing D, Krissat J et al (2000) Percutaneous portal vein embolization increases the feasibility and safety of major liver resection for hepatocellular carcinoma in injured liver. Ann Surg 232:665–672
doi: 10.1097/00000658-200011000-00008
pubmed: 11066138
pmcid: 1421241
Azoulay D, Castaing D, Smail A et al (2000) Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization. Ann Surg 231:480–486
doi: 10.1097/00000658-200004000-00005
pubmed: 10749607
pmcid: 1421022
Yang X, Qiu Y, Huang B et al (2018) Novel techniques and preliminary results of ex vivo liver resection and autotransplantation for end-stage hepatic alveolar echinococcosis: A study of 31 cases. Am J Transplant 18(7):1668–1679. https://doi.org/10.1111/ajt.14621 . Epub 2018 Jan 21
Qiang W, Jun Y, Xiabin F et al (2017) Safety and efficacy of radiofrequency-assisted ALPPS (RALPPS) in patients with cirrhosis-related hepatocellular carcinoma. Int J Hyperth 33:846–852. https://doi.org/10.1080/02656736.2017.1303752
doi: 10.1080/02656736.2017.1303752
Azoulay D, Lim C, Salloum C et al (2015) Complex Liver Resection Using Standard Total Vascular Exclusion, Venovenous Bypass, and in situ hypothermic Portal Perfusion: an audit of 77 consecutive cases. Ann Surg 262(1):93–104. https://doi.org/10.1097/SLA.0000000000000787
doi: 10.1097/SLA.0000000000000787
pubmed: 24950284
Zhang Y, Xie P, Yang C et al (2021) The Value of Hepatic Vein Stent Placement as a Bridge Therapy on Treating Hepatic Alveolar Echinococcosis Presenting With Budd-Chiari Syndrome. Ann Surg 273(4):e154–e156. https://doi.org/10.1097/SLA.0000000000004648 . PMID: 33214482
Oldhafer F, Ringe KI, Timrott K et al (2018) Modified ante situm liver resection without use of cold perfusion nor veno-venous bypass for treatment of hepatic lesions infiltrating the hepatocaval confluence. Langenbeck’s Arch Surg 403(3):379–386
doi: 10.1007/s00423-018-1658-1
Azoulay D, Maggi U, Lim C et al (2014) Liver resection using total vascular exclusion of the liver preserving the caval flow, in situ hypothermic portal perfusion and temporary porta-caval shunt: a new technique for central tumors. Hepatobiliary Surg Nutr 3(3):149–153. https://doi.org/10.3978/j.issn.2304-3881.2014.05.02
doi: 10.3978/j.issn.2304-3881.2014.05.02
pubmed: 25019076
pmcid: 4073321
Azoulay D, Eshkenazy R, Andreani P et al (2005) In situ hypothermic perfusion of the liver versus standard total vascular exclusion for complex liver resection. Ann Surg 241(2):277–285. https://doi.org/10.1097/01.sla.0000152017.62778.2f
doi: 10.1097/01.sla.0000152017.62778.2f
pubmed: 15650638
pmcid: 1356913
Belzer FO, Southard JH (1988) Principles of solid-organ preservation by cold storage. Transplantation 45:673–676
doi: 10.1097/00007890-198804000-00001
pubmed: 3282347
Bogner A, Reissfelder C, Striebel F et al (2021) Intraoperative increase of portal venous pressure is an Immediate Predictor of Posthepatectomy Liver failure after Major Hepatectomy: a prospective study. Ann Surg 274(1):e10–e17. https://doi.org/10.1097/SLA.0000000000003496
doi: 10.1097/SLA.0000000000003496
pubmed: 31356261
Allard MA, Adam R, Bucur PO et al (2013) Posthepatectomy portal vein pressure predicts liver failure and mortality after major liver resection on noncirrhotic liver. Ann Surg 258(5):822–829 discussion 829 – 30. https://doi.org/10.1097/SLA.0b013e3182a64b38
doi: 10.1097/SLA.0b013e3182a64b38
pubmed: 24045452
Ito T, Kiuchi T, Yamamoto H et al (2003) Changes in portal venous pressure in the early phase after living donor liver transplantation: pathogenesis and clinical implications. Transplantation 75(8):1313–1317. https://doi.org/10.1097/01.TP.0000063707.90525.10
doi: 10.1097/01.TP.0000063707.90525.10
pubmed: 12717222
Carrapita JG, Rocha C, Donato H et al (2019) Portal venous pressure variation during Hepatectomy: a prospective study. Acta Med Port 32(6):420–426. https://doi.org/10.20344/amp.10892
doi: 10.20344/amp.10892
pubmed: 31292022